Teleflex Inc (TFX)
203.11
+2.15
(+1.07%)
USD |
NYSE |
May 07, 12:58
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 9.567B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -21.62% |
Valuation | |
PE Ratio | 32.60 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 3.203 |
Price to Book Value | 2.124 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.34 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.3905 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 59.09% |
Profile
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder. |
URL | https://www.teleflex.com |
Investor Relations URL | https://investors.teleflex.com |
HQ State/Province | Pennsylvania |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Mid Cap/Blend |
Next Earnings Release | Aug. 02, 2024 (est.) |
Last Earnings Release | May. 02, 2024 |
Next Ex-Dividend Date | May. 14, 2024 |
Last Ex-Dividend Date | Feb. 29, 2024 |
Ratings
Profile
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder. |
URL | https://www.teleflex.com |
Investor Relations URL | https://investors.teleflex.com |
HQ State/Province | Pennsylvania |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Mid Cap/Blend |
Next Earnings Release | Aug. 02, 2024 (est.) |
Last Earnings Release | May. 02, 2024 |
Next Ex-Dividend Date | May. 14, 2024 |
Last Ex-Dividend Date | Feb. 29, 2024 |